Related Experiment Video

Updated: May 2, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.6K

Effect of mobile phone short text messages on glycaemic control in children with type 1 diabetes

Bassam Bin-Abbas1, Musleh Jabbari, Abdullah Al-Fares

  • 1Department of Pediatrics, Security Forces Hospital, Riyadh, Saudi Arabia.

Journal of Telemedicine and Telecare
|March 20, 2014
PubMed

Insights

Mobile phone messaging improved type 1 diabetes management in young patients. This study showed better blood glucose control and increased adherence to therapy for children and adolescents with diabetes.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Digital Health

Background:

  • Type 1 diabetes management in children and adolescents requires consistent monitoring and adherence to therapy.
  • Traditional follow-up methods may present challenges in maintaining engagement and providing timely support.
  • Mobile technology offers a potential avenue for enhanced patient-provider communication and education.

Purpose of the Study:

  • To assess the feasibility and impact of a mobile phone messaging service for pediatric patients with type 1 diabetes.
  • To evaluate the service's effect on glycemic control, adherence, and parental knowledge.
  • To determine if mobile messaging can improve clinical outcomes in this population.

Main Methods:

  • A six-month feasibility study involving 200 children and adolescents with type 1 diabetes.
  • Participants received daily informational, weekly interactive, and on-demand multimedia video messages via mobile phone (through parents).
  • Clinical outcomes (fasting blood glucose, postprandial blood glucose, HbA1c, hypoglycemia frequency, monitoring frequency) and parental knowledge were assessed before and after the trial.

Main Results:

  • Significant reductions observed in mean fasting blood glucose (150 to 133 mg/dl, P < 0.001), postprandial blood glucose, HbA1c, and hypoglycemia frequency.
  • A significant decrease in the frequency of blood glucose monitoring was noted.
  • Parental knowledge regarding diabetes management significantly improved during the trial.

Conclusions:

  • Mobile phone text messaging is a feasible and effective tool for supporting type 1 diabetes care in children and adolescents.
  • The service demonstrated improvements in clinical outcomes, including better glycemic control and reduced hypoglycemia.
  • Enhanced adherence to diabetes therapy and improved parental understanding were key benefits, suggesting mobile messaging's value in pediatric diabetes management.

More Related Videos

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

1.2K
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

25.3K

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.3K
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
30
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
45
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K